Ratiometric 3D DNA Machine Combined with Machine Learning Algorithm for Ultrasensitive and High-Precision Screening of Early Urinary Diseases

Abstract

Urinary extracellular vesicles (uEVs) have received considerable attention as a potential biomarker source for the diagnosis of urinary diseases. Present studies mainly focus on the discovery of biomarkers based on high-throughput proteomics, while limited efforts have been paid to applying the uEVs’ biomarkers for the diagnosis of early urinary disease. Herein, we demonstrate a diagnosis protocol to realize ultrasensitive detection of uEVs and accurate classification of early urinary diseases, by combing a ratiometric three-dimensional (3D) DNA machine with machine learning (ML). The ratiometric 3D DNA machine platform is constructed by conjugating a padlock probe (PLP) containing cytosine-rich (C-rich) sequences, anchor strands, and nucleic-acid-stabilized silver nanoclusters (DNAAgNCs) onto the magnetic nanoparticles (MNPs). The competitive binding of uEVs with the aptamer releases the walker strand, thus the ratiometric 3D DNA machine was activated to undergo an accurate amplification reaction and produce a ratiometric fluorescence signal. The present biosensor offers a detection limit of 9.9 × 103 particles mL–1 with a linear range of 104–108 particles mL–1 for uEVs. Two ML algorithms, K-nearest neighbor (KNN) and support vector machine (SVM), were subsequently applied for analyzing the correlation between the sensing signals of uEV multibiomarkers and the clinical state. The disease diagnostic accuracy of optimal biomarker combination reaches 95% and 100% by analyzing with KNN and SVM, and the disease type classification exhibits an accuracy of 94.7% and 89.5%, respectively. Moreover, the protocol results in 100% accurate visual identification of clinical uEV samples from individuals with disease or as healthy control by a t-distributed stochastic neighbor embedding (tSNE) algorithm.

Decreased resting-state neural signal in the left angular gyrus as a potential neuroimaging biomarker of schizophrenia: An amplitude of low-frequency fluctuation and support vector machine analysis

“…The application of support vector machine (SVM)-based artificial intelligence methods has been increasingly used to aid in predicting therapeutic outcomes or accurately diagnosing specific conditions (25,26). Multivariate pattern recognitionbased SVM methods allow for the detection of patterns within a given dataset, and are well-suited to analyzing high-dimensional data in which there are more features than there are observations, as is common in experimental settings (27).…”

Exosomes as a new frontier of cancer liquid biopsy

“…Wu et al used the fluorescent signal of urine-derived exosomes as input data, and KNN (K-Nearest Neightbors) and SVM serving as machine learning models, were applied for exosomal biomarker analysis. By introducing machine learning algorithm, the diagnostic model could make an accurate diagnosis and classification of multiple diseases [ 188 ]. Liu et al used LDA to determine a sum signature of seven exosomal biomarkers, which achieved a high accuracy in discriminating prostate cancer from benign disease [ 68 ].…”

Surface Engineering of Lipid Vesicles Based on DNA Nanotechnology

“…[90] As shown in Figure 8, Wu and coworkers analyzed a variety of biomarkers on the membrane surface of extracellular vesicles in urine (uEVs) by combining the ratiometric 3D DNA machines with algorithm analysis, thus realizing high-sensitivity and high-precision screening of early urinary system diseases. [91] The method was to construct ratiometric 3D DNA machines by combining cytosine-rich sequences, anchor chains, and nucleic acid-stabilized silver nanocluster padlock probes to magnetic nanoparticles (MNPs). The competitive binding of uEVs with aptamer released walker chain, which activated 3D DNA machines to carry out rolling circle amplification reaction and generated ratio fluorescence signal.…”

“…b) The ratiometric 3D DNA machine was combined with algorithmic analysis to analyze various biomarkers on the membrane surface of urinary extracellular vesicles (uEVs) to realize the diagnosis and classification of urinary system diseases. Reproduced fromRef [91]. with permission from the American Chemical Society.…”